Supreme Drugs Pvt Ltd

Palanpur, Gujarat, India
Small Molecule API Generic Formulations Inhalation (development) Excipients Generics (ANDA/DMF)
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Supreme Drugs Pvt Ltd

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
Palanpur, Gujarat, India
Modalities
Small Molecule API, Generic Formulations, Inhalation (development), Excipients, Generics (ANDA/DMF)
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Supreme Drugs Pvt Ltd

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesSmall Molecule API, Generic Formulations, Inhalation (development), Excipients, Generics (ANDA/DMF)
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (5 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Broad modality coverage (5 modalities)

Frequently Asked Questions About Supreme Drugs Pvt Ltd

What is Supreme Drugs Pvt Ltd's CDMO Signal Score?
Supreme Drugs Pvt Ltd has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Supreme Drugs Pvt Ltd for a manufacturing program?
Use the free AI matchmaker to compare Supreme Drugs Pvt Ltd against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Sun Pharmaceutical Industries Ltd.
Mumbai, India
Small Molecule API, Oral Solid Dose, Sterile Injectables, Specialty Generics, Novel Chemical Entities (NCE) via CRAMS, Biologics (via CMO partnerships), Specialty/Innovative Medicines
Sai Life Sciences
Hyderabad, India
Small Molecule API, Complex Small Molecules, HPAPI, ADC, Peptides, Oligonucleotides, Lipids / LNP, Intermediates, Drug Discovery (CRO)
Torrent Pharmaceuticals Limited
Ahmedabad, India
Small Molecule API, Oral Solid Dose, Sterile Injectables, Generic Drug Products, CDMO (via JB Pharma acquisition)
Aarti Pharmalabs Limited
Mumbai, India
Small Molecule API, Steroid / Corticosteroid API, HPAPI, Anti-cancer / Cytotoxic API, Xanthine Derivatives, NCE Drug Substance
Laurus Labs
Hyderabad, India
Small Molecule API, Finished Dosage Form (FDF), CDMO (small molecule), Biologics / Large Molecule, Microbial Fermentation, Peptide API, Cell & Gene Therapy (early-stage investment), Anti-retroviral API, Oncology API, ADC (emerging)